Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chadwick M Hales

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Molecular Neurodegeneration|April 30, 2014
U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer's disease due to autosomal dominant genetic mutations and trisomy 21Chadwick M Hales, Nicholas T Seyfried, Eric B Dammer, et al.
Cell Reports|April 28, 2021
5-hydroxymethylcytosine is dynamically regulated during forebrain organoid development and aberrantly altered in Alzheimer's diseaseJanise N Kuehner, Junyu Chen, Emily C Bruggeman, et al.
Alzheimer'S Research & Therapy|September 7, 2021
Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer's diseaseKamil Borkowski, Theresa L Pedersen, Nicholas T Seyfried, et al.
Proteomics|October 9, 2016
Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progressionChadwick M Hales, Eric B Dammer, Qiudong Deng, et al.
The Journal of Biological Chemistry|October 31, 2014
Aggregation properties of the small nuclear ribonucleoprotein U1-70K in Alzheimer diseaseIan Diner, Chadwick M Hales, Isaac Bishof, et al.
Molecular Neurodegeneration|June 26, 2016
Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementiaChristopher J Holler, Georgia Taylor, Zachary T McEachin, et al.
Disease Models & Mechanisms|August 5, 2016
A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responsesMarcela K Preininger, Rajneesh Jha, Joshua T Maxwell, et al.
Molecular Neurodegeneration|June 30, 2018
Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteinsSrikant Rangaraju, Eric B Dammer, Syed Ali Raza, et al.
Molecular Neurodegeneration|June 26, 2021
A proteomic network approach resolves stage-specific molecular phenotypes in chronic traumatic encephalopathyLaura Gutierrez-Quiceno, Eric B Dammer, Ashlyn Grace Johnson, et al.
Journal of Neuropathology and Experimental Neurology|October 17, 2013
Abnormal gephyrin immunoreactivity associated with Alzheimer disease pathologic changesChadwick M Hales, Howard Rees, Nicholas T Seyfried, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Molecular Neurodegeneration|April 30, 2014
U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer's disease due to autosomal dominant genetic mutations and trisomy 21Chadwick M Hales, Nicholas T Seyfried, Eric B Dammer, et al.
Cell Reports|April 28, 2021
5-hydroxymethylcytosine is dynamically regulated during forebrain organoid development and aberrantly altered in Alzheimer's diseaseJanise N Kuehner, Junyu Chen, Emily C Bruggeman, et al.
Alzheimer'S Research & Therapy|September 7, 2021
Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer's diseaseKamil Borkowski, Theresa L Pedersen, Nicholas T Seyfried, et al.
Proteomics|October 9, 2016
Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progressionChadwick M Hales, Eric B Dammer, Qiudong Deng, et al.
The Journal of Biological Chemistry|October 31, 2014
Aggregation properties of the small nuclear ribonucleoprotein U1-70K in Alzheimer diseaseIan Diner, Chadwick M Hales, Isaac Bishof, et al.
Molecular Neurodegeneration|June 26, 2016
Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementiaChristopher J Holler, Georgia Taylor, Zachary T McEachin, et al.
Disease Models & Mechanisms|August 5, 2016
A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responsesMarcela K Preininger, Rajneesh Jha, Joshua T Maxwell, et al.
Molecular Neurodegeneration|June 30, 2018
Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteinsSrikant Rangaraju, Eric B Dammer, Syed Ali Raza, et al.
Molecular Neurodegeneration|June 26, 2021
A proteomic network approach resolves stage-specific molecular phenotypes in chronic traumatic encephalopathyLaura Gutierrez-Quiceno, Eric B Dammer, Ashlyn Grace Johnson, et al.
Journal of Neuropathology and Experimental Neurology|October 17, 2013
Abnormal gephyrin immunoreactivity associated with Alzheimer disease pathologic changesChadwick M Hales, Howard Rees, Nicholas T Seyfried, et al.
Pageof 6